Tower Research Capital LLC (Trc) Neoleukin Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.5 - $0.72 $1,570 - $2,260	-3,140 Reduced 83.47%	622 $0
Q4 2022 Feb 10, 2023	SELL	$0.4 - $0.55 $2,484 - $3,416	-6,212 Reduced 62.28%	3,762 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.69 - $1.33 $238 - $460	346 Added 3.59%	9,974 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.92 - $2.25 $2,462 - $6,023	2,677 Added 38.51%	9,628 $10,000
Q1 2022 May 12, 2022	SELL	$1.72 - $5.23 $318 - $967	-185 Reduced 2.59%	6,951 $13,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $13,494 - $22,490	2,902 Added 68.54%	7,136 $35,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $9.66 $8,330 - $13,301	1,377 Added 48.2%	4,234 $31,000
Q2 2021 Aug 16, 2021	BUY	$9.23 - $13.12 $11,454 - $16,281	1,241 Added 76.79%	2,857 $26,000
Q1 2021 May 17, 2021	SELL	$11.26 - $15.78 $6,429 - $9,010	-571 Reduced 26.11%	1,616 $20,000
Q4 2020 Feb 16, 2021	SELL	$10.17 - $14.56 $242,981 - $347,867	-23,892 Reduced 91.61%	2,187 $31,000
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $238,186 - $418,548	24,606 Added 1670.47%	26,079 $313,000
Q2 2020 Aug 13, 2020	SELL	$9.95 - $17.05 $5,363 - $9,189	-539 Reduced 26.79%	1,473 $24,000
Q1 2020 May 15, 2020	BUY	$6.12 - $13.64 $12,313 - $27,443	2,012 New	2,012 $23,000
Q4 2019 Feb 07, 2020	SELL	$2.65 - $12.72 $20,913 - $100,386	-7,892 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$2.33 - $3.76 $18,388 - $29,673	7,892 New	7,892 $22,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.